Tax Planning and Incentive Models for Life Sciences companies
Given the new international standards on corporate taxation, Switzerland is currently undergoing a major corporate tax reform to remain an attractive business location.
In this context, Life Sciences companies will be impacted by OECD’s work on Base Erosion and Profit Shifting (BEPS) and the Swiss Corporate Tax Reform III for their IP planning and R&D activities.
The Speakers will present and discuss the new requirements and opportunities from a tax standpoint.
17h00 – 17h30 Registrations
17h30 – 17h40 Welcoming words
17h40 – 18h00 IP planning and R&D activities in light of BEPS, Peter Dörrfuß, Partner, Life Sciences Leader Tax, EY
18h00 – 18h20 IP planning and R&D activities in light of the Swiss Corporate Tax Reform III, Christian Aivazian, Executive Director, Corporate Tax, EY
18h20 – 18h40 The view of the taxpayer
18h40 – 19h00 Roundtable discussion and Q&As with Peter Dörrfuß, Christian Aivazian, EY client/prospect
19h00 : end of conference and beginning of networking session & cocktail.
We are very pleased to welcome you to this event!
Online Ticket Purchasing
(payment upon invoice for 200CHF is possible by emailing at firstname.lastname@example.org)
– Full package ticket : 150 CHF
– Start-ups (<10 employees, <2years): 50 CHF
– Register for 5 events (5th is free): 600 CHF
Venue: Campus Biotech, Geneva. Entry from Rue Kazem-Radjavi (side of Campus)